Partial myeloid inhibition of key glycolytic enzyme PFKFB3 increases hepatic steatosis and inflammation, but does not affect atherosclerosis — R. Tillie (2023) | RDL Network
R. Tillie, Jenny de Bruijn, Javier Perales-Patón, Lieve Temmerman, Yanal Ghosheh, Kim van Kuijk, Marion J. Gijbels, Peter Carmeliet, Klaus Ley, Julio Sáez-Rodríguez, Judith C. Sluimer
Anna Rita Cantelmo, Lena-Christin Conradi, Aleksandra Brajic, Jermaine Goveia, Joanna Kalucka, Andreas Pircher, Pallavi Chaturvedi, Johanna Hol Fosse, Bernard Thienpont, Laure-Anne Teuwen, Sandra Schoors, Bram Boeckx, Joris Vriens, Anna Kuchnio, Koen Veys, Bert Cruys, Lise Finotto, Lucas Treps, Tor Espen Stav-Noraas, Francesco Bifari, Peter C. Stapor, Ilaria Decimo, Kim R. Kampen,
Discussion(0)
No comments yet. Be the first to comment.